Grant: Collaborative Research and Development Grants
University of British Columbia
$45,230.00
Biomarkers for haemic neoplasia in the blue mussel, mytilus trossulus
FY 2007-08
Summary
The overall objective of this research is to develop biomarkers for a leukemia-like disease in mussels called haemic neoplasia (HN). This disease has a high prevalence in Mytilus trossulus, the species native to the British Columbia coast. Although the disease likely has a virus aetiology there are some indications that susceptibility of individuals to the disease is exacerbated in the presence of pollutants. The mussel is used widely as a bioindicator organism, and is being evaluated as a potential monitoring tool for the Greater Vancouver Regional District (GVRD) receiving environment-monitoring program for one wastewater treatment plant. Haemic neoplasia is one of the various endpoints being evaluated. Our goal is to develop high throughput techniques such as gene expression analysis for monitoring of this disease. Our hypothesis is that apoptosis processes are impaired in leukemic mussel haemocytes (LMH). We propose to test this hypothesis by subjecting LMH to various apoptosis inducing agents. Knowing which pathways are dysregulated in LMH will help identify potential biomarkers for this disease. We are already monitoring the pro-apoptotic genes p53 and p63/p73 in a separate study. To extend the number of biomarker genes, and as a second objective of this proposal, we aim to sequence MDM2, an anti-apoptotic gene, and develop a quantitative polymerase chain reaction protocol so that MDM2 gene expression in LMH can be monitored also. Monitoring multiple biomarkers that include both protagonists and antagonists of a particular pathway gives more information about potential dysregulation of that pathway.
Program
Collaborative Research and Development Grants
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
349918-2006
Name nom
Baldwin, Susan
Department département
Chemical and Biological Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2006
Award amount
45230
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
702
Area of application group en
Transportation systems and services
Area of application group fr
Services et systèmes de transport
Area of application en
Water
Area of application fr
Maritime
Research subject code
1501
Research subject group en
Environmental engineering
Research subject group fr
Génie de l'environnement
Research subject en
Water quality, pollution
Research subject fr
Qualité de l'eau, pollution
Partie
1
Nb partie
1
Application title
Biomarkers for haemic neoplasia in the blue mussel, mytilus trossulus
Keyword
NA
Application summary
The overall objective of this research is to develop biomarkers for a leukemia-like disease in mussels called haemic neoplasia (HN). This disease has a high prevalence in Mytilus trossulus, the species native to the British Columbia coast. Although the disease likely has a virus aetiology there are some indications that susceptibility of individuals to the disease is exacerbated in the presence of pollutants. The mussel is used widely as a bioindicator organism, and is being evaluated as a potential monitoring tool for the Greater Vancouver Regional District (GVRD) receiving environment-monitoring program for one wastewater treatment plant. Haemic neoplasia is one of the various endpoints being evaluated. Our goal is to develop high throughput techniques such as gene expression analysis for monitoring of this disease. Our hypothesis is that apoptosis processes are impaired in leukemic mussel haemocytes (LMH). We propose to test this hypothesis by subjecting LMH to various apoptosis inducing agents. Knowing which pathways are dysregulated in LMH will help identify potential biomarkers for this disease. We are already monitoring the pro-apoptotic genes p53 and p63/p73 in a separate study. To extend the number of biomarker genes, and as a second objective of this proposal, we aim to sequence MDM2, an anti-apoptotic gene, and develop a quantitative polymerase chain reaction protocol so that MDM2 gene expression in LMH can be monitored also. Monitoring multiple biomarkers that include both protagonists and antagonists of a particular pathway gives more information about potential dysregulation of that pathway.